<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Sung" />


<title>Antibody Discovery Platform</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>







<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Antibody Discovery Platform</h1>
<h4 class="author">Sung</h4>


<div id="TOC">
<ul>
<li><a href="#antibody-discovery-platforms" id="toc-antibody-discovery-platforms">Antibody Discovery
Platforms</a></li>
<li><a href="#bcr-seq" id="toc-bcr-seq">BCR-seq</a></li>
<li><a href="#utility-of-bcr-seq" id="toc-utility-of-bcr-seq">Utility of
BCR-seq</a></li>
<li><a href="#bcr-seq-analysis-tools" id="toc-bcr-seq-analysis-tools">BCR-seq analysis tools</a></li>
</ul>
</div>

<p><br><br></p>
<div id="antibody-discovery-platforms" class="section level2">
<h2>Antibody Discovery Platforms</h2>
<ol style="list-style-type: decimal">
<li><strong>Phage Display Technology</strong>:
<ul>
<li>Phage display is a versatile technique that involves expressing
peptide or protein libraries on the surface of bacteriophages (viruses
that infect bacteria). This method is used for screening large libraries
of variants to identify those that bind with high affinity to specific
targets.</li>
</ul></li>
<li><strong>Yeast Display</strong>:
<ul>
<li>Similar to phage display, yeast display involves expressing the
antibody libraries on the surface of yeast cells. This method is
beneficial for screening because of the eukaryotic post-translational
modifications that yeast can perform, which are important for the
function of many antibodies.</li>
</ul></li>
<li><strong>Single B Cell Technologies</strong>:
<ul>
<li>This approach involves isolating individual B cells (the cells
responsible for antibody production in the immune system) to capture and
sequence the antibody genes they produce. Technologies like
microfluidics and single-cell sequencing have enhanced the throughput
and precision of this method.</li>
</ul></li>
<li><strong>Next-Generation Sequencing (NGS)</strong>:
<ul>
<li>NGS of the <strong>B-cell receptor repertoire</strong> allows for an
in-depth analysis of the diversity of antibody responses. This method
can generate vast amounts of data on <strong>the sequence
variability</strong> in the immune response, aiding in the
identification of highly effective antibodies.</li>
</ul></li>
<li><strong>Transgenic Mice</strong>:
<ul>
<li>These are mice genetically engineered to produce human antibodies
when exposed to an antigen. This technology allows for the generation of
fully human antibodies directly in a living organism, which can then be
further tested and developed for therapeutic use.</li>
</ul></li>
<li><strong>Mass Spectrometry-Based Antibody Profiling</strong>:
<ul>
<li>Advanced mass spectrometry techniques are now being used to analyze
<strong>the structure and function of antibodies at a molecular
level.</strong> This helps in understanding the complex structure of
antibody-antigen interactions and improves the selection of candidates
with the best therapeutic potential.</li>
</ul></li>
<li><strong>Artificial Intelligence and Machine Learning</strong>:
<ul>
<li>AI and machine learning are increasingly being integrated into
antibody discovery platforms to predict antibody structures, optimize
antibody-antigen interactions, and enhance the selection process for
potential therapeutic antibodies.</li>
</ul></li>
</ol>
</div>
<div id="bcr-seq" class="section level2">
<h2>BCR-seq</h2>
<ol style="list-style-type: decimal">
<li><strong>Clonotype Identification</strong>:
<ul>
<li>The primary goal in analyzing BCR-seq data is to identify
clonotypes, which are unique BCR sequences that can indicate clonal
expansions in response to specific antigens. Advanced bioinformatics
tools are used to assemble these sequences from short reads, identify
the variable (V), diversity (D), and joining (J) gene segments, and
annotate the complementarity-determining region 3 (CDR3), crucial for
antigen specificity.</li>
</ul></li>
<li><strong>Diversity Analysis</strong>:
<ul>
<li>BCR-seq allows for the measurement of repertoire diversity, which is
key to understanding the breadth of the immune response. Metrics such as
diversity indices and clonal richness can be calculated to assess how
broad or focused the immune response is.</li>
</ul></li>
<li><strong>Somatic Hypermutation Analysis</strong>:
<ul>
<li>Analyzing the patterns and rates of somatic hypermutations within
BCR sequences helps in understanding how B cells evolve to refine their
affinity for antigens. This aspect is particularly important in chronic
infections and cancer, where ongoing antigen stimulation is
prevalent.</li>
</ul></li>
<li><strong>Longitudinal Monitoring</strong>:
<ul>
<li>BCR-seq can be performed over time to monitor changes in the B-cell
repertoire in response to interventions such as vaccination, infection,
or autoimmune disease progression. This longitudinal analysis can reveal
how the immune repertoire adapts over time.</li>
</ul></li>
</ol>
</div>
<div id="utility-of-bcr-seq" class="section level2">
<h2>Utility of BCR-seq</h2>
<ol style="list-style-type: decimal">
<li><strong>Vaccine Development</strong>:
<ul>
<li>BCR-seq is extensively used in vaccine research to identify the
characteristics of protective antibodies. This information can guide the
design of vaccines that elicit potent and broad immune responses.</li>
</ul></li>
<li><strong>Cancer Immunotherapy</strong>:
<ul>
<li>In cancer, BCR-seq is used to explore the diversity and dynamics of
tumor-infiltrating B cells, which can contribute to anti-tumor immunity.
Understanding BCRs in the tumor microenvironment can help in designing B
cell-mediated immunotherapeutic strategies.</li>
</ul></li>
<li><strong>Autoimmune Disease Research</strong>:
<ul>
<li>By identifying autoreactive clonotypes, BCR-seq helps in
understanding the etiology of autoimmune diseases and can contribute to
the development of targeted therapies that modulate harmful immune
responses.</li>
</ul></li>
<li><strong>Infection Response Analysis</strong>:
<ul>
<li>BCR-seq is critical in studying the evolution of the immune response
during infection, particularly for rapidly evolving viruses. This can
inform treatment strategies and provide insights into immune evasion
mechanisms.</li>
</ul></li>
<li><strong>Diagnostic Tool</strong>:
<ul>
<li>BCR-seq has potential as a diagnostic tool, particularly in
immunodeficiency disorders, by assessing the health and diversity of the
immune repertoire.</li>
</ul></li>
</ol>
</div>
<div id="bcr-seq-analysis-tools" class="section level2">
<h2>BCR-seq analysis tools</h2>
<ul>
<li><a href="https://liulab-dfci.github.io/RIMA/Repertoire.html">Immune
repertoire analysis (TCR/BCR-seq)</a><br></li>
<li><a href="https://immcantation.readthedocs.io/en/stable/getting_started/10x_tutorial.html">Immcantation
(BCR-seq: Integration of BCR and GEX Data) 10X Genomics</a><br></li>
<li><a href="https://immunarch.com/articles/web_only/BCRpipeline.html">immuarch</a><br></li>
</ul>
<p><br><br><br><br></p>
<!-- <br> Update: "2024-06-11" -->
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
